ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Moffitt Cancer Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Moffitt Cancer Center takes part in 8 sessions at ESMO 2026 in Madrid. Its work spans treatment and outcomes across melanoma, breast, prostate, colorectal and lung cancers. It examines nivolumab with HBI-8000 or placebo in advanced melanoma.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
US National Cancer Institute-designated comprehensive cancer centre in Tampa, Florida, combining patient care and research.
Abstract
Fri Oct 23
16:25–16:35
Chair
Sat Oct 24
10:15–11:45
Challenging clinical scenarios in melanoma and skin cancers
with Hôpital Saint-Louis (AP-HP)
Melanoma & skin cancers
Talk
Sat Oct 24
10:55–11:15
Adolescents and Young Adults (including oncofertility)
Challenging clinical scenarios in melanoma and skin cancers
Melanoma & skin cancers
Poster
Sat Oct 24
12:00–12:45
Host inherited genetic variation and the risk of hepatitis following immune checkpoint immunotherapy (ICI) of melanoma
Saturday Poster Display session 4
Melanoma & skin cancersBiomarkers & precision oncology
Abstract
Sun Oct 25
10:25–10:35
Poster
Mon Oct 26
12:00–12:45

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Moffitt Cancer Center

Tell us what you sell and we’ll find the people at Moffitt Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction